Brought to you by 
Baxter sells Transfusion Therapies division
02 Mar 2007
Executive Summary
Baxter will sell its Transfusion Therapies division (formerly Fenwal; develops and manufactures blood collection and processing systems) to private equity firm Texas Pacific Group and Maverick Capital for $540mm.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Baxter sells Transfusion Therapies division
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice